These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 14070792)

  • 1. CARCINOMAS OF THE EXTRAHEPATIC BILIARY SYSTEM.
    PALLETTE EM; HARRINGTON RW; PALLETTE EC
    Am Surg; 1963 Oct; 29():719-23. PubMed ID: 14070792
    [No Abstract]   [Full Text] [Related]  

  • 2. Descriptive study of gallbladder, extrahepatic bile duct, and ampullary cancers in the United States, 1997-2002.
    Goodman MT; Yamamoto J
    Cancer Causes Control; 2007 May; 18(4):415-22. PubMed ID: 17264972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers.
    Nakazawa K; Dobashi Y; Suzuki S; Fujii H; Takeda Y; Ooi A
    J Pathol; 2005 Jul; 206(3):356-65. PubMed ID: 15892172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoma of the pancreas and extrahepatic biliary system.
    Salmon PA
    Surgery; 1966 Sep; 60(3):554-65. PubMed ID: 5913779
    [No Abstract]   [Full Text] [Related]  

  • 5. ENDOGENOUS CARCINOGENS FOR THE EXTRAHEPATIC BILIARY TRACT.
    FORTNER JG; RANDALL HT
    Acta Unio Int Contra Cancrum; 1963; 19():629-31. PubMed ID: 14050622
    [No Abstract]   [Full Text] [Related]  

  • 6. CANCER OF THE BILIARY TREE.
    DENBESTEN L; LIECHTY RD
    Am J Surg; 1965 May; 109():587-9. PubMed ID: 14281879
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cancer of the extrahepatic biliary tract].
    Bärlehner E; Fischer M
    Z Arztl Fortbild (Jena); 1982 Jan; 76(1-2):49-53. PubMed ID: 7080524
    [No Abstract]   [Full Text] [Related]  

  • 8. [Malignant bile duct diseases and jaundice].
    Mukai H; Nakajima M; Yasuda K; Hirano S; Mochizuki N; Tanaka K; Uno K; Tojo M
    Nihon Naika Gakkai Zasshi; 1997 Apr; 86(4):620-8. PubMed ID: 9198654
    [No Abstract]   [Full Text] [Related]  

  • 9. Status of surgical treatment of biliary tract cancer.
    Ishihara S; Miyakawa S; Takada T; Takasaki K; Nimura Y; Tanaka M; Miyazaki M; Nagakawa T; Kayahara M; Horiguchi A
    Dig Surg; 2007; 24(2):131-6. PubMed ID: 17446708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biliary carcinoma risk in patients with pancreaticobiliary maljunction and the degree of extrahepatic bile duct dilatation.
    Kamisawa T; Tu Y; Kuwata G; Egawa N; Nakajima H; Tsuruta K; Okamoto A; Matsukawa M
    Hepatogastroenterology; 2006; 53(72):816-8. PubMed ID: 17153430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoplastic precursors of the gallbladder and extrahepatic biliary system.
    Adsay NV
    Gastroenterol Clin North Am; 2007 Dec; 36(4):889-900, vii. PubMed ID: 17996796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of carcinoma of the papilla of Vater.
    Fischer HP; Zhou H
    J Hepatobiliary Pancreat Surg; 2004; 11(5):301-9. PubMed ID: 15549428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factor for extrahepatic bile duct cancer in patients with anomalous pancreaticobiliary ductal union.
    Jung YS; Lee KJ; Kim H; Kim WH; Kim IG; Yoo BM; Kim JH; Kim MW
    Hepatogastroenterology; 2004; 51(58):946-9. PubMed ID: 15239220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
    Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.
    Hansel DE; Maitra A; Lin JW; Goggins M; Argani P; Yeo CJ; Piantadosi S; Leach SD; Biankin AV
    J Clin Oncol; 2005 Mar; 23(9):1811-8. PubMed ID: 15774774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for extrahepatic biliary tract carcinoma in men: medical conditions and lifestyle: results from a European multicentre case-control study.
    Ahrens W; Timmer A; Vyberg M; Fletcher T; Guénel P; Merler E; Merletti F; Morales M; Olsson H; Olsen J; Hardell L; Kaerlev L; Raverdy N; Lynge E
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):623-30. PubMed ID: 17625430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left hemihepatectomy and caudate lobectomy and complete extrahepatic bile duct resection using transduodenal approach for hilar cholangiocarcinoma arsing from biliary papillomatosis.
    Kim JK; Hwang HK; Park JS; Cho SI; Yoon DS; Chi HS
    J Surg Oncol; 2008 Aug; 98(2):139-42. PubMed ID: 18521837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.
    Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
    Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreas-preserving biliary amputation with pancreatic diversion: a new surgical technique for complete resection of the intrapancreatic biliary system.
    Kondo S; Hirano S; Ambo Y; Tanaka E; Morikawa T; Okushiba S; Katoh H
    Hepatogastroenterology; 2004; 51(59):1255-8. PubMed ID: 15362726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Malignant adenomatosis of the biliary tract with favorable anatomoclinical evolution].
    DE LA TORRE FERNANDEZ JM; AMO GALAN A; GALLEGO TEJEDOR M
    Rev Esp Enferm Apar Dig Nutr; 1962; 21():907-19. PubMed ID: 14025850
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.